Quibim

Quibim ? Advancing Precision Medicine Through AI-Powered Imaging

Quibim is a biotechnology company specializing in artificial intelligence (AI) solutions for medical imaging. Founded in 2015 and headquartered in Valencia, Spain, Quibim develops advanced imaging biomarkers and AI-driven tools to enhance diagnostics, treatment planning, and drug development across various medical fields.

What Is Quibim?

Quibim, short for Quantitative Imaging Biomarkers in Medicine, offers a cloud-based platform that integrates and analyzes medical imaging data using AI. By extracting quantitative biomarkers from imaging modalities like MRI, CT, and PET, Quibim enables healthcare providers and researchers to gain deeper insights into disease mechanisms, improve patient stratification, and personalize treatment approaches.

Key Features

1. QP-Insights? ? Comprehensive Data Management

• Centralizes storage and analysis of multi-omics and imaging data.
• Harmonizes imaging data to minimize variability across different equipment and protocols.
• Ensures compliance with data security standards, including ISO 27001, HIPAA, and GDPR.

2. QP-Link? ? Seamless PACS Integration

• Facilitates automated transfer of imaging studies between local systems and the Quibim cloud.
• Supports data pseudonymization or anonymization to protect patient privacy.
• Enables real-time analysis and retrieval of results directly into existing workflows.

3. AI-Powered Imaging Analysis

• Employs over 24 AI algorithms to detect patterns and quantify imaging biomarkers.
• Supports applications in oncology, neurology, hepatology, and more.
• Enhances diagnostic accuracy and reduces manual workload for clinicians.

4. Specialized Software Solutions

• QP-Prostate?: Automates prostate MRI analysis, providing lesion detection and standardized reporting.
• QP-Brain?: Analyzes brain volumetrics and white matter hyperintensities to assist in neurological assessments.
• QP-Liver?: Quantifies liver fat and iron content, aiding in the diagnosis and monitoring of liver diseases.

Who Is It For?

• Healthcare Providers: Radiologists and clinicians seeking advanced tools for image analysis and diagnosis.
• Researchers: Institutions conducting studies that require quantitative imaging biomarkers.
• Pharmaceutical Companies: Organizations involved in drug development and clinical trials needing imaging-based endpoints.
• Hospitals and Clinics: Facilities aiming to integrate AI-driven imaging solutions into their existing systems.

Benefits of Using Quibim

• Enhanced Diagnostic Precision: Provides quantitative data to support clinical decisions.
• Workflow Efficiency: Automates image analysis, reducing time and potential for human error.
• Data Security: Ensures patient data is protected through compliance with international standards.
• Research Advancement: Facilitates the discovery of new biomarkers and supports large-scale studies.
• Scalability: Offers solutions adaptable to various sizes and types of healthcare institutions.

Pricing Overview

Quibim provides customized pricing based on the specific needs and scale of the institution. Factors influencing pricing include the number of modules implemented, volume of data processed, and level of integration required. Interested parties should contact Quibim directly to obtain a tailored quote.

FAQs

Q1: What types of imaging modalities does Quibim support?
Quibim’s platform is compatible with MRI, CT, and PET imaging modalities.

Q2: Can Quibim’s solutions be integrated into existing hospital systems?
Yes, Quibim offers seamless integration with existing Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHRs).

Q3: Is patient data secure when using Quibim’s platform?
Absolutely. Quibim adheres to ISO 27001 standards and complies with HIPAA and GDPR regulations to ensure data security and patient privacy.

Q4: Does Quibim offer support for clinical trials?
Yes, Quibim’s platform is designed to support clinical trials by providing quantitative imaging biomarkers and facilitating patient stratification.

Q5: Are Quibim’s AI algorithms validated for clinical use?
Quibim’s AI algorithms undergo rigorous validation processes and have received regulatory clearances, including CE marking and FDA approval for specific applications.